Private Equity
Foundation Capital, Neocarta Ventures, Rho Ventures, Scale Venture Partners, WF Holding Company and seven other venture investors collectively own 18.6 million shares worth about $260 million at the IPO price.
2 min read · 11 April 2014
Clal Biotechnology Industries owns 9,789,555 shares worth about $137 million at the IPO price.
1 min read · 11 April 2014
Advent Life Sciences, Aisling Capital, Amunix, Fidelity, Index Ventures, New Leaf Ventures and Sofinnova Venture Partners own 14,770,487 shares worth about $310 million at the IPO price.
1 min read · 11 April 2014
Jaidev Shergill, Capital One’s head of digital venture investing, to head up fintech-focused unit
2 min read · 04 April 2014
Round makes private company one of Silicon Valley’s most richly valued
2 min read · 02 April 2014
London-based investor, which focuses on U.S. and European healthcare deals, raises $376 million for sixth Bioventures fund
2 min read · 01 April 2014
Accelerators across Russia; lower Russian VC spending;
4 min read · 01 April 2014
New commitment for Ireland; Icelandic fund pool; pensions in Danish M&A
3 min read · 01 April 2014
Corporate COO goes VC; New execs at Oxford; three join small-biz investor
3 min read · 01 April 2014
Singh of Crystal Tech aims to raise $50 million, Metamorphic wraps up second fund and RRE begins raising its sixth
6 min read · 01 April 2014
